StrokeEPTASNCT06165666
Effectiveness of Physiotherapy After Stroke
A study testing Approach by functional objectives and Treatment protocol in people with Stroke, run by University of Alcala at 1 site in Spain.
Trial summary
The World Health Organization (WHO) defines Stroke or Cerebrovascular Accident as clinical sign of focal disorder in brain functioning of rapid onset, with a presumed vascular origin and duration of more than 24 hours. Read more about this study
- Who is it for?
- Ages 50 years and older
- Conditions the study is for
- Stroke
- What is being tested?
- Approach by functional objectives and Treatment protocol
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 8 participants
- Where
- 1 siteSpain
- Study dates
- 12 Feb 2024to 31 Oct 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Having been diagnosed with stroke between 6 and 24 months before the intervention.
- Age 50 or more years.
- Have signed the informed consent.
Who cannot join
- Present moderate or severe cognitive impairment according to the Pfeiffer Questionnaire.
- Have other serious diseases with a significant impact on functional capacity.
- Suffer previously diagnosed psychiatric pathology.
- Being dependent for activities of daily living before suffering the stroke.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effectiveness of Physiotherapy for Improving Functionality, Participation and Quality of Life After a Stroke: Single-blind Randomized Controlled Clinical Trial
The World Health Organization (WHO) defines Stroke or Cerebrovascular Accident as clinical sign of focal disorder in brain functioning of rapid onset, with a presumed vascular origin and duration of more than 24 hours. It represents the first cause of physical disability in adults, and approximately half of people who survive stroke present motor and sensitivity disorders, which cause alterations in functionality, especially in activities of daily living, with the consequent impact negative in participation in the environment and the quality of life of people and their families.
The objective of the study is to know the effectiveness of a Physiotherapy intervention, based on the achievement of objectives, in improving functionality, participation and quality of life after a Stroke compared to treatment protocol.
Methodology: single-blind randomized controlled clinical trial. The sample of 62 subjects (31 in each group) will be recruited at the Ramon y Cajal University Hospital. The Physiotherapy intervention will consist of 30 sessions, 3 times/week, for 10 consecutive weeks, in which the treatment for the Experimental Group will be based on training of specific tasks aimed at functional objectives previously agreed upon with the person/user vs. the Control Group who will receive a conventional Physiotherapy treatment protocol. The outcome variables are: perception of quality of life (Spanish version of The Newcastle Stroke-specific Quality of Life Measure); degree of functional disability (Barthel Index); level of gait functionality (Spanish version of Functional Ambulation Categories); dynamic balance and trunk control (Spanish version of Trunk Impairment Scale); postural control (Spanish version of the Postural Assessment Scale for Stroke Patients); and participation in the environment (Spanish version of the Oxford Participation and Activities Questionnaire). They will be collected at three times: before starting the study, initial assessment (V0), at the end of the intervention for each group, intermediate assessment (V1) and 6 months after V0 (V2).
Read the detailed description
Background:
According to the WHO, stroke represents the first cause of physical disability in the adult population, as well as the second cause of death in industrialized and developed countries, becoming a pathology of great socioeconomic cost. The number of people suffering from stroke, worldwide, has increased considerably in recent decades, especially since the beginning of the global pandemic, presenting itself as a complication of COVID19. In Spain, the incidence of stroke ranges between 150 and 323 cases per 100,000 inhabitants. Its frequency increases with age, especially in the population over 65 years of age, and it is considered that after six months of having suffered a stroke, 26.1% of people die, 41.5% of those affected are independent, and 32.4% have some type of functional dependency.
Among the most frequent sequelae, motor impairment stands out, which is usually considered the main cause of disability in people due to its impact on balance, causing gait disorders and an increased risk of falls, as well as difficulty in handling and performance of activities of daily living (ADL). When these alterations persist over time, they not only hinder functionality but also interfere with the interaction with the environment and the subject's participation in social activities, negatively affecting the perception of their quality of life. This is why Physiotherapy interventions that include training in functional activities are an optimal approach strategy. Recently, based on the International Classification of Functioning, Disability and Health, a paradigm shift is occurring in the treatment of the functionality of people who have suffered a stroke. The European Stroke Organization indicates that during motor recovery, patients learn to optimize their motor, sensory and cognitive functioning through repetitive, goal-oriented, progressive and task-specific training. And here it is worth highlighting the importance of the functional orientation of physiotherapy to help these people maximize health, well-being and quality of life.
Physiotherapy treatment after stroke carries a high cost as it requires specialized personnel in a multidisciplinary team because it is a long-term individualized therapy. Instead of limiting ourselves to teaching compensation methods to recover mobility, motor control and lost balance, it has been proposed to focus on the nervous system's ability to recover previous movement patterns, through functional use and neuroplasticity. Establishing functional goals could be the key to effective decision making, as well as a person-centered outcome measure for Stroke rehabilitation. Based on all this, we consider that the Physiotherapy intervention should be based on the needs of the person instead of pre-established treatment designs.
The latest systematic reviews carried out show that the impact of methodologies based on functionality compared to conventional treatments has not yet been rigorously evaluated. Optimizing physiotherapy treatment would allow us to improve the patient's level of recovery after a stroke, reducing dependency rates and increasing their quality of life, while reducing the number of sessions necessary and the waiting list to access treatment.
Objective:Know the effectiveness of a Physiotherapy intervention, based on the achievement of objectives in improving functionality, participation and quality of life after a Stroke compared to treatment protocol.
Design: Single-blind, parallel, randomized controlled clinical trial, 1:1 allocation ratio and with third-party evaluation. The study has been approved by the Research Ethics Committee of the Ramon y Cajal University Hospital (220/23).
Study population
Inclusion criteria:
- Diagnosis of Stroke between 6 and 24 months before to study access.
- Age ≥ 50 years.
- Signing of the informed consent.
In order to detect differences in functionality, participation and quality of life in favor of the experimental group, a large effect size of d = 0.80, an error α = 0.05 and a power of 90% is assumed. Considering a possible loss to follow-up of 10%, the sample size results in 62 participants.
Methodology: participants are randomly assigned into 2 groups (intervention group (EG) and control group (CG)). All participants will receive as a therapeutic approach 3 sessions/week of 40' duration, for 10 weeks.
The therapeutic approach that will be administered to the EG will be based on the training of specific tasks aimed at functional objectives. Each session will begin with activities to activate the muscles of the trunk, pelvis and lower limbs, to modify atypical movement patterns and prepare the muscles for a more effective contraction. Subsequently, activity training will be carried out in a functional and meaningful context, aimed at specific and significant functional objectives for the participant and previously agreed upon with them. In these sessions, aspects such as postural orientation and stability, movement components and the ability to perform selective movement are taken into account.
The therapeutic approach of the participants assigned to the CG will be aimed at maintaining joint ranges and transfer work, passive mobilization of the paretic lower and upper limb, maintenance of sitting posture with/without assistance, transfer from sitting to standing, from standing to sitting. and coordination work. Subsequently, initiation of walking with a support product and/or help, if possible.
Variables: Perception of quality of life (Spanish version of The Newcastle Stroke-specific Quality of Life Measure. Degree of functional disability (Barthel Index), Functional level of gait (Spanish version of the "Functional Ambulation Categories. Dynamic balance) and trunk control (Spanish version of the Trunk Impairment Scale, Postural control (Spanish version of the Postural Assessment Scale for Stroke and Participation in the environment (Spanish version of the Oxford Participation and Activities Questionnaire. The following will also be collected: age, sex, weight, height, type of stroke, evolution time and most affected hemibody.
Data collection and analysis: data will be collected three times throughout the process: (V0), start of the study; (V1) end of intervention period and (V2), six months after the start of the study. After the measurements (V0, V1 and V2), the data will be analyzed with the Statistical Package for the Social Sciences software, version 25 for Mac.
Descriptive statistics will be performed using means and standard deviations, in the case of quantitative variables with a normal distribution, or medians and interquartile ranges, failing that. Normality will be studied using the Kolmogorov-Smirnov test. For nominal qualitative variables, absolute and relative percentage frequencies will be used.
The homogeneity of descriptive variables and initial outcome variables will be analyzed with the Student t test for independent samples (homoscedastic normal quantitative variables), with the Welch t test (non-heteroscedastic normal quantitative variables) or with the Mann-Whitney U test. (non-normal quantitative variables). In the case of nominal qualitative variables, Pearson's Chi-square test or Fisher's exact test will be used.
To study the differences between the experimental group and the control group, the Student t test for independent samples, the Welch t test or the Mann-Whitney U test will be used.
The database used in the study will be created in the RedCAP system, with the collaboration of the Ramon y Cajal Institute for Health Research Data Science Unit, a secure and structured database that allows open access to information at the institutional level, complying with Open Sciences requirements.
- Conditions
- Stroke
- Being tested
- Approach by functional objectives, Treatment protocol
- Keywords
- stroke, physiotherapy, clinical trial
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Approach by functional objectivesOther
The therapeutic approach that will be administered to the EG will be based on the training of specific tasks aimed at functional objectives. Each session will begin with activities to activate the muscles of the trunk, pelvis and lower limbs, to modify atypical movement patterns and prepare the muscles for a more effective contraction. Subsequently, activity training will be carried out in a functional and meaningful context, aimed at specific and significant functional objectives for the participant and previously agreed upon with them.
Treatment protocolOther
The therapeutic approach of the participants assigned to the CG will be aimed at maintaining joint ranges and transfer work, passive mobilization of the paretic lower and upper limb, maintenance of sitting posture with/without assistance, transfer from sitting to standing, from standing to sitting. and coordination work. Subsequently, initiation of walking with a support product and/or help, if possible.
| Study group | Role | What they receive |
|---|---|---|
| intervention group (EG) | Experimental | The participants will receive as a therapeutic approach 3 physical therapy sessions/week of 40' duration, for 10 weeks. Receives: Other: Approach by functional objectives |
| control group (CG) | Active comparator | The participants will receive as a therapeutic approach 3 physical therapy sessions/week of 40' duration, for 10 weeks. Receives: Other: Treatment protocol |
What is being measured
The primary outcome is the main question the study is designed to answer.
Perception of quality of life
Spanish version of NewsQoL
Measured: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Functional disability
Barthel index
Measured: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Participation in the environment
Spanish version Oxford Participation and Activities Questionnaire
Measured: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Secondary outcomes (3)
Level of gait functionality
Spanish version of the Functional Ambulation Categories
Measured: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Dynamic balance and trunk control
Spanish version of the Trunk Impairment Scale
Measured: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Postural control
Spanish version of the Postural Assessment Scale for Stroke Patients
Measured: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Dec 2023
- Study start12 Feb 2024
- Primary completion30 Apr 2025 (estimated)
- Study completion31 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants are randomly assigned into 2 groups (intervention group (EG) and control group (CG)).
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 8 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Alcala
- Sponsor type
- University, hospital or other
- Collaborators
- Hospital Universitario Ramon y Cajal
- Responsible party
- Principal investigator, Concepción Soto-Vidal, University of Alcala
- Investigators
- Concepción Soto-Vidal, Principal investigator, University of Alcala
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06165666
- Sponsor's protocol ID
- Stroke Project
- Acronym
- EPTAS
- Status last verified
- May 2024
- First submitted
- 1 Dec 2023
- Last updated
- 31 May 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Murie-Fernandez M, Irimia P, Martinez-Vila E, John Meyer M, Teasell R. [Neuro-rehabilitation after stroke]. Neurologia. 2010 Apr;25(3):189-96. Spanish.
PubMed 20492866Wonsetler EC, Bowden MG. A systematic review of mechanisms of gait speed change post-stroke. Part 2: exercise capacity, muscle activation, kinetics, and kinematics. Top Stroke Rehabil. 2017 Jul;24(5):394-403. doi: 10.1080/10749357.2017.1282413. Epub 2017 Feb 20.
PubMed 28218021Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, Tu TM, Sharma VK, Yeo LLL, Chan BPL, Tan BYQ. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020 Oct;50(3):587-595. doi: 10.1007/s11239-020-02228-y.
PubMed 32661757Alessandro L, Olmos LE, Bonamico L, Muzio DM, Ahumada MH, Russo MJ, Allegri RF, Gianella MG, Campora H, Delorme R, Vescovo ME, Lado V, Mastroberti LR, Butus A, Galluzzi HD, Decima G, Ameriso SF. [Multidisciplinary rehabilitation for adult patients with stroke]. Medicina (B Aires). 2020;80(1):54-68. Spanish.
PubMed 32044742Kwakkel G, Stinear C, Essers B, Munoz-Novoa M, Branscheidt M, Cabanas-Valdes R, Lakicevic S, Lampropoulou S, Luft AR, Marque P, Moore SA, Solomon JM, Swinnen E, Turolla A, Alt Murphy M, Verheyden G. Motor rehabilitation after stroke: European Stroke Organisation (ESO) consensus-based definition and guiding framework. Eur Stroke J. 2023 Dec;8(4):880-894. doi: 10.1177/23969873231191304. Epub 2023 Aug 7.
PubMed 37548025Leonardi M, Fheodoroff K. Goal Setting with ICF (International Classification of Functioning, Disability and Health) and Multidisciplinary Team Approach in Stroke Rehabilitation. 2021 Jan 15. In: Platz T, editor. Clinical Pathways in Stroke Rehabilitation: Evidence-based Clinical Practice Recommendations [Internet]. Cham (CH): Springer; 2021. Available from http://www.ncbi.nlm.nih.gov/books/NBK585584/
PubMed 36315695Rosewilliam S, Roskell CA, Pandyan AD. A systematic review and synthesis of the quantitative and qualitative evidence behind patient-centred goal setting in stroke rehabilitation. Clin Rehabil. 2011 Jun;25(6):501-14. doi: 10.1177/0269215510394467. Epub 2011 Mar 25.
PubMed 21441308Sugavanam T, Mead G, Bulley C, Donaghy M, van Wijck F. The effects and experiences of goal setting in stroke rehabilitation - a systematic review. Disabil Rehabil. 2013 Feb;35(3):177-90. doi: 10.3109/09638288.2012.690501. Epub 2012 Jun 7.
PubMed 22671934Azevedo da Costa F, Araujo da Silva DL, da Rocha VM. [The functional condition of patients following a cerebrovascular accident]. Rev Neurol. 2006 May 16-31;42(10):591-5. Spanish.
PubMed 16703526Soto-Vidal C, Calvo-Fuente V, Hidalgo-Galante E, Cerezo-Tellez E, Perez-Martin Y, Pacheco-da-Costa S. Effectiveness of Physiotherapy for Improving Functionality, Participation, and Quality of Life after a Stroke: Study Protocol for a Randomized Controlled Clinical Trial. J Pers Med. 2024 Aug 22;14(8):891. doi: 10.3390/jpm14080891.
PubMed 39202082
Study at a glance
From the registry record, last updated by the sponsor on 31 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Physiotherapy for Improving Functionality, Participation and Quality of Life After a Stroke: Single-blind Randomized Controlled Clinical Trial
- ClinicalTrials.gov ID
- NCT06165666
- Acronym / sponsor ID
- EPTAS / Stroke Project
- Conditions
- Stroke
- Keywords
- stroke, physiotherapy, clinical trial
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 8 participants (actual)
- Lead sponsor
- University of AlcalaUniversity, hospital or other
- Collaborators
- Hospital Universitario Ramon y Cajal
- Study start
- 12 Feb 2024 (actual)
- Primary completion
- 30 Apr 2025 (estimated)
- Study completion
- 31 Oct 2026 (estimated)
- First posted
- 11 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The World Health Organization (WHO) defines Stroke or Cerebrovascular Accident as clinical sign of focal disorder in brain functioning of rapid onset, with a presumed vascular origin and duration of more than 24 hours. It represents the first cause of physical disability in adults, and approximately half of people who survive stroke present motor and sensitivity disorders, which cause alterations in functionality, especially in activities of daily living, with the consequent impact negative in participation in the environment and the quality of life of people and their families.
The objective of the study is to know the effectiveness of a Physiotherapy intervention, based on the achievement of objectives, in improving functionality, participation and quality of life after a Stroke compared to treatment protocol.
Methodology: single-blind randomized controlled clinical trial. The sample of 62 subjects (31 in each group) will be recruited at the Ramon y Cajal University Hospital. The Physiotherapy intervention will consist of 30 sessions, 3 times/week, for 10 consecutive weeks, in which the treatment for the Experimental Group will be based on training of specific tasks aimed at functional objectives previously agreed upon with the person/user vs. the Control Group who will receive a conventional Physiotherapy treatment protocol. The outcome variables are: perception of quality of life (Spanish version of The Newcastle Stroke-specific Quality of Life Measure); degree of functional disability (Barthel Index); level of gait functionality (Spanish version of Functional Ambulation Categories); dynamic balance and trunk control (Spanish version of Trunk Impairment Scale); postural control (Spanish version of the Postural Assessment Scale for Stroke Patients); and participation in the environment (Spanish version of the Oxford Participation and Activities Questionnaire). They will be collected at three times: before starting the study, initial assessment (V0), at the end of the intervention for each group, intermediate assessment (V1) and 6 months after V0 (V2).
Detailed description
Background:
According to the WHO, stroke represents the first cause of physical disability in the adult population, as well as the second cause of death in industrialized and developed countries, becoming a pathology of great socioeconomic cost. The number of people suffering from stroke, worldwide, has increased considerably in recent decades, especially since the beginning of the global pandemic, presenting itself as a complication of COVID19. In Spain, the incidence of stroke ranges between 150 and 323 cases per 100,000 inhabitants. Its frequency increases with age, especially in the population over 65 years of age, and it is considered that after six months of having suffered a stroke, 26.1% of people die, 41.5% of those affected are independent, and 32.4% have some type of functional dependency.
Among the most frequent sequelae, motor impairment stands out, which is usually considered the main cause of disability in people due to its impact on balance, causing gait disorders and an increased risk of falls, as well as difficulty in handling and performance of activities of daily living (ADL). When these alterations persist over time, they not only hinder functionality but also interfere with the interaction with the environment and the subject's participation in social activities, negatively affecting the perception of their quality of life. This is why Physiotherapy interventions that include training in functional activities are an optimal approach strategy. Recently, based on the International Classification of Functioning, Disability and Health, a paradigm shift is occurring in the treatment of the functionality of people who have suffered a stroke. The European Stroke Organization indicates that during motor recovery, patients learn to optimize their motor, sensory and cognitive functioning through repetitive, goal-oriented, progressive and task-specific training. And here it is worth highlighting the importance of the functional orientation of physiotherapy to help these people maximize health, well-being and quality of life.
Physiotherapy treatment after stroke carries a high cost as it requires specialized personnel in a multidisciplinary team because it is a long-term individualized therapy. Instead of limiting ourselves to teaching compensation methods to recover mobility, motor control and lost balance, it has been proposed to focus on the nervous system's ability to recover previous movement patterns, through functional use and neuroplasticity. Establishing functional goals could be the key to effective decision making, as well as a person-centered outcome measure for Stroke rehabilitation. Based on all this, we consider that the Physiotherapy intervention should be based on the needs of the person instead of pre-established treatment designs.
The latest systematic reviews carried out show that the impact of methodologies based on functionality compared to conventional treatments has not yet been rigorously evaluated. Optimizing physiotherapy treatment would allow us to improve the patient's level of recovery after a stroke, reducing dependency rates and increasing their quality of life, while reducing the number of sessions necessary and the waiting list to access treatment.
Objective:Know the effectiveness of a Physiotherapy intervention, based on the achievement of objectives in improving functionality, participation and quality of life after a Stroke compared to treatment protocol.
Design: Single-blind, parallel, randomized controlled clinical trial, 1:1 allocation ratio and with third-party evaluation. The study has been approved by the Research Ethics Committee of the Ramon y Cajal University Hospital (220/23).
Study population
Inclusion criteria:
- Diagnosis of Stroke between 6 and 24 months before to study access.
- Age ≥ 50 years.
- Signing of the informed consent.
In order to detect differences in functionality, participation and quality of life in favor of the experimental group, a large effect size of d = 0.80, an error α = 0.05 and a power of 90% is assumed. Considering a possible loss to follow-up of 10%, the sample size results in 62 participants.
Methodology: participants are randomly assigned into 2 groups (intervention group (EG) and control group (CG)). All participants will receive as a therapeutic approach 3 sessions/week of 40' duration, for 10 weeks.
The therapeutic approach that will be administered to the EG will be based on the training of specific tasks aimed at functional objectives. Each session will begin with activities to activate the muscles of the trunk, pelvis and lower limbs, to modify atypical movement patterns and prepare the muscles for a more effective contraction. Subsequently, activity training will be carried out in a functional and meaningful context, aimed at specific and significant functional objectives for the participant and previously agreed upon with them. In these sessions, aspects such as postural orientation and stability, movement components and the ability to perform selective movement are taken into account.
The therapeutic approach of the participants assigned to the CG will be aimed at maintaining joint ranges and transfer work, passive mobilization of the paretic lower and upper limb, maintenance of sitting posture with/without assistance, transfer from sitting to standing, from standing to sitting. and coordination work. Subsequently, initiation of walking with a support product and/or help, if possible.
Variables: Perception of quality of life (Spanish version of The Newcastle Stroke-specific Quality of Life Measure. Degree of functional disability (Barthel Index), Functional level of gait (Spanish version of the "Functional Ambulation Categories. Dynamic balance) and trunk control (Spanish version of the Trunk Impairment Scale, Postural control (Spanish version of the Postural Assessment Scale for Stroke and Participation in the environment (Spanish version of the Oxford Participation and Activities Questionnaire. The following will also be collected: age, sex, weight, height, type of stroke, evolution time and most affected hemibody.
Data collection and analysis: data will be collected three times throughout the process: (V0), start of the study; (V1) end of intervention period and (V2), six months after the start of the study. After the measurements (V0, V1 and V2), the data will be analyzed with the Statistical Package for the Social Sciences software, version 25 for Mac.
Descriptive statistics will be performed using means and standard deviations, in the case of quantitative variables with a normal distribution, or medians and interquartile ranges, failing that. Normality will be studied using the Kolmogorov-Smirnov test. For nominal qualitative variables, absolute and relative percentage frequencies will be used.
The homogeneity of descriptive variables and initial outcome variables will be analyzed with the Student t test for independent samples (homoscedastic normal quantitative variables), with the Welch t test (non-heteroscedastic normal quantitative variables) or with the Mann-Whitney U test. (non-normal quantitative variables). In the case of nominal qualitative variables, Pearson's Chi-square test or Fisher's exact test will be used.
To study the differences between the experimental group and the control group, the Student t test for independent samples, the Welch t test or the Mann-Whitney U test will be used.
The database used in the study will be created in the RedCAP system, with the collaboration of the Ramon y Cajal Institute for Health Research Data Science Unit, a secure and structured database that allows open access to information at the institutional level, complying with Open Sciences requirements.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Participants are randomly assigned into 2 groups (intervention group (EG) and control group (CG)).
| Arm | Type | Receives |
|---|---|---|
| intervention group (EG) | Experimental | Other: Approach by functional objectivesThe participants will receive as a therapeutic approach 3 physical therapy sessions/week of 40' duration, for 10 weeks. |
| control group (CG) | Active comparator | Other: Treatment protocolThe participants will receive as a therapeutic approach 3 physical therapy sessions/week of 40' duration, for 10 weeks. |
Who may qualify
- Ages
- 50 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Having been diagnosed with stroke between 6 and 24 months before the intervention.
- Age 50 or more years.
- Have signed the informed consent.
Key exclusion criteria (4 listed)
- Present moderate or severe cognitive impairment according to the Pfeiffer Questionnaire.
- Have other serious diseases with a significant impact on functional capacity.
- Suffer previously diagnosed psychiatric pathology.
- Being dependent for activities of daily living before suffering the stroke.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Approach by functional objectivesThe therapeutic approach that will be administered to the EG will be based on the training of specific tasks aimed at functional objectives. Each session will begin with activities to activate the muscles of the trunk, pelvis and lower limbs, to modify atypical movement patterns and prepare the muscles for a more effective contraction. Subsequently, activity training will be carried out in a functional and meaningful context, aimed at specific and significant functional objectives for the participant and previously agreed upon with them. | Other | intervention group (EG) |
| Treatment protocolThe therapeutic approach of the participants assigned to the CG will be aimed at maintaining joint ranges and transfer work, passive mobilization of the paretic lower and upper limb, maintenance of sitting posture with/without assistance, transfer from sitting to standing, from standing to sitting. and coordination work. Subsequently, initiation of walking with a support product and/or help, if possible. | Other | control group (CG) |
Primary outcome
Perception of quality of life
Time frame: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Spanish version of NewsQoL
Functional disability
Time frame: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Barthel index
Participation in the environment
Time frame: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Spanish version Oxford Participation and Activities Questionnaire
3 secondary outcomes
Level of gait functionality
Time frame: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Dynamic balance and trunk control
Time frame: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Postural control
Time frame: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 May 2024.
- Background: PubMed 20492866Murie-Fernandez M, Irimia P, Martinez-Vila E, John Meyer M, Teasell R. [Neuro-rehabilitation after stroke]. Neurologia. 2010 Apr;25(3):189-96. Spanish.
- Background: PubMed 28218021Wonsetler EC, Bowden MG. A systematic review of mechanisms of gait speed change post-stroke. Part 2: exercise capacity, muscle activation, kinetics, and kinematics. Top Stroke Rehabil. 2017 Jul;24(5):394-403. doi: 10.1080/10749357.2017.1282413. Epub 2017 Feb 20.
- Background: PubMed 32661757Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, Tu TM, Sharma VK, Yeo LLL, Chan BPL, Tan BYQ. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020 Oct;50(3):587-595. doi: 10.1007/s11239-020-02228-y.
- Background: PubMed 32044742Alessandro L, Olmos LE, Bonamico L, Muzio DM, Ahumada MH, Russo MJ, Allegri RF, Gianella MG, Campora H, Delorme R, Vescovo ME, Lado V, Mastroberti LR, Butus A, Galluzzi HD, Decima G, Ameriso SF. [Multidisciplinary rehabilitation for adult patients with stroke]. Medicina (B Aires). 2020;80(1):54-68. Spanish.
- Background: PubMed 37548025Kwakkel G, Stinear C, Essers B, Munoz-Novoa M, Branscheidt M, Cabanas-Valdes R, Lakicevic S, Lampropoulou S, Luft AR, Marque P, Moore SA, Solomon JM, Swinnen E, Turolla A, Alt Murphy M, Verheyden G. Motor rehabilitation after stroke: European Stroke Organisation (ESO) consensus-based definition and guiding framework. Eur Stroke J. 2023 Dec;8(4):880-894. doi: 10.1177/23969873231191304. Epub 2023 Aug 7.
- Background: PubMed 36315695Leonardi M, Fheodoroff K. Goal Setting with ICF (International Classification of Functioning, Disability and Health) and Multidisciplinary Team Approach in Stroke Rehabilitation. 2021 Jan 15. In: Platz T, editor. Clinical Pathways in Stroke Rehabilitation: Evidence-based Clinical Practice Recommendations [Internet]. Cham (CH): Springer; 2021. Available from http://www.ncbi.nlm.nih.gov/books/NBK585584/
- Background: PubMed 21441308Rosewilliam S, Roskell CA, Pandyan AD. A systematic review and synthesis of the quantitative and qualitative evidence behind patient-centred goal setting in stroke rehabilitation. Clin Rehabil. 2011 Jun;25(6):501-14. doi: 10.1177/0269215510394467. Epub 2011 Mar 25.
- Background: PubMed 22671934Sugavanam T, Mead G, Bulley C, Donaghy M, van Wijck F. The effects and experiences of goal setting in stroke rehabilitation - a systematic review. Disabil Rehabil. 2013 Feb;35(3):177-90. doi: 10.3109/09638288.2012.690501. Epub 2012 Jun 7.
- Results publication: PubMed 16703526Azevedo da Costa F, Araujo da Silva DL, da Rocha VM. [The functional condition of patients following a cerebrovascular accident]. Rev Neurol. 2006 May 16-31;42(10):591-5. Spanish.
- Derived from this study: PubMed 39202082Soto-Vidal C, Calvo-Fuente V, Hidalgo-Galante E, Cerezo-Tellez E, Perez-Martin Y, Pacheco-da-Costa S. Effectiveness of Physiotherapy for Improving Functionality, Participation, and Quality of Life after a Stroke: Study Protocol for a Randomized Controlled Clinical Trial. J Pers Med. 2024 Aug 22;14(8):891. doi: 10.3390/jpm14080891.
- Individual participant dataSharing planned: No
Related trials for Stroke
Recruiting
The AHA Oneida Study
Oneida Nation Members
Active, not recruiting
Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO)
Acute Ischemic Stroke
Active, not recruiting
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
Ischemic Stroke, Systemic Embolism
RecruitingPhase 3
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease
Active, not recruiting
Brain Connectivity Analysis
Neural Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Concepción Soto-Vidal principal investigator
University of Alcala
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Approach by functional objectives and Treatment protocol in people with Stroke, run by University of Alcala at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 31 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Perception of quality of life (time frame: Beginning of the study, end of the therapeutic intervention period and 6 months after the start of the study.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06165666, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2024.